Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $243.34 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $217.26 | 2 | $0 (2022) |
| Fidia Pharma USA Inc. | $13.57 | 1 | $0 (2023) |
| Genentech USA, Inc. | $12.51 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.57 | 1 | Fidia Pharma USA Inc. ($13.57) |
| 2022 | $133.92 | 2 | Gilead Sciences, Inc. ($121.41) |
| 2021 | $95.85 | 1 | Gilead Sciences, Inc. ($95.85) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2023 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/17/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: HIV | ||||||
| 02/01/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Virology & Specialty Care | ||||||
| 06/23/2021 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 86 | 87 | $8,068 | $4,106 |
| 2022 | 5 | 147 | 159 | $14,405 | $6,713 |
| 2021 | 4 | 141 | 149 | $10,938 | $5,480 |
| 2020 | 4 | 91 | 91 | $6,402 | $3,468 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $1,380 | $1,352 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $3,870 | $1,220 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,104 | $916.73 | 43.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $714.00 | $616.56 | 86.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $5,721 | $2,329 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 34 | $3,676 | $1,923 | 52.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 36 | 37 | $2,775 | $1,875 | 67.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 19 | 22 | $550.00 | $357.87 | 65.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $1,683 | $227.73 | 13.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 49 | 53 | $3,975 | $2,719 | 68.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 34 | 34 | $3,366 | $1,158 | 34.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $2,071 | $1,132 | 54.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 39 | 43 | $1,526 | $470.72 | 30.8% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 31 | 31 | $3,069 | $1,364 | 44.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 19 | $949.81 | $949.81 | 100.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 18 | 18 | $1,923 | $784.19 | 40.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $460.00 | $369.61 | 80.4% |
About Daniel Gallagher
Daniel Gallagher is a Family healthcare provider based in Hamilton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1033583976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Gallagher has received a total of $243.34 in payments from pharmaceutical and medical device companies, with $13.57 received in 2023. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($243.34).
As a Medicare-enrolled provider, Gallagher has provided services to 465 Medicare beneficiaries, totaling 486 services with total Medicare billing of $19,766. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Hamilton, OH
- Active Since 11/16/2015
- Last Updated 08/01/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1033583976
Products in Payments
- Descovy (Drug) $217.26
- HYMOVIS (Device) $13.57
- Xofluza (Drug) $12.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hamilton
Margaret Phillips, Pmhnp-Bc, Fnp-C, PMHNP-BC, FNP-C
Family — Payments: $6,368
Mrs. Mary Leyendecker, Np, NP
Family — Payments: $3,703
Theresa Falk, Fnp, FNP
Family — Payments: $2,815
Heather Scrimpshire, Np, NP
Family — Payments: $1,472
Jennifer Newman, Np-C, NP-C
Family — Payments: $1,453
Stephanie Marano, Msn,Apn,Fnp-Bc,Cmsrn, MSN,APN,FNP-BC,CMSRN
Family — Payments: $1,398